Exelixis (EXEL) Other Non Operating Income (2010 - 2026)
Exelixis' (EXEL) quarterly Other Non Operating Income came in at $219000.0 in Q2 2026, up 189.39% year-on-year from $75677.0 in Q2 2025, and up 376.09% quarter-over-quarter from $46000.0 in Q1 2026.
Exelixis (EXEL) Other Non Operating Income (2010 - 2026) Analysis & Trends
Exelixis' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $219000.0 for Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 189.39% year-over-year to $219000.0 in Q2 2026; TTM through Apr 2026 was $266000.0, a 192.04% increase from a year earlier, with the FY2026 full-year figure at -$198000.0, down 48.87% from the prior year.
- Other Non Operating Income improved to $219000.0 in Q2 2026 per EXEL's latest filing, from $46000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $289000.0 in Q3 2023 and bottomed at -$337000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is -$29000.0 (2024), against an average of -$12705.9.
- Across the five-year window, Other Non Operating Income surged 518.84% in 2023 and sank 5640.0% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$337000.0 in 2022, then surged by 59.35% to -$137000.0 in 2023, then jumped by 78.83% to -$29000.0 in 2024, then plunged by 68.97% to -$49000.0 in 2025, then soared by 546.94% to $219000.0 in 2026.
- Per Business Quant, the three latest EXEL Other Non Operating Income figures stand at $219000.0 (Q2 2026), $46000.0 (Q1 2026), and -$49000.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 219,000.00 |
| Jan 2, 2026 | 46,000.00 |
| Oct 3, 2025 | -49,000.00 |
| Jul 4, 2025 | 50,000.00 |
| Apr 4, 2025 | -245,000.00 |
| Jan 3, 2025 | 272,000.00 |
| Sep 27, 2024 | -29,000.00 |
| Jun 28, 2024 | -287,000.00 |
| Mar 29, 2024 | -89,000.00 |
| Dec 29, 2023 | -137,000.00 |
| Sep 29, 2023 | 289,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Mar 31, 2023 | -54,000.00 |
| Dec 30, 2022 | -337,000.00 |
| Sep 30, 2022 | -69,000.00 |
| Jul 1, 2022 | 45,000.00 |
| Apr 1, 2022 | 164,000.00 |
| Dec 31, 2021 | -64,000.00 |
| Oct 1, 2021 | -19,000.00 |
| Jul 2, 2021 | -11,000.00 |